Literature DB >> 9202608

Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues.

A M Connolly1, A Pestronk, S Mehta, M R Pranzatelli, M J Noetzel.   

Abstract

OBJECTIVE: Opsoclonus-myoclonus (OM) is a rare neurologic syndrome affecting children and adults. In children it occurs as a parainfectious process or a paraneoplastic syndrome in association with neuroblastoma. Evidence for an immune mechanism includes the presence of serum autoantibodies to several neural antigens and improvement of symptoms with immunosuppressive therapy. We studied the neural antigenic targets of serum IgM and IgG autoantibodies from nine children with OM.
DESIGN: We studied sera from nine children with OM, three with associated neuroblastoma and six with a prodromal viral illness. Control subjects (n = 77) included four children with neuroblastoma but not OM, 32 children with other neurologic disorders, and 41 with nonneurologic illnesses. We studied the neural antigenic targets of serum IgM and IgG autoantibodies by the following methods: (1) immunostaining of human cerebellar sections and peripheral nerve, and (2) Western blot analysis with human brain fractions including white matter, gray matter, and cerebellar Purkinje cells and nuclei.
RESULTS: Sera from all nine children with OM had IgM and IgG binding to the cytoplasm of cerebellar Purkinje cells and to some axons in white matter. In peripheral nerve, IgM and IgG from all nine OM sera bound to large and small axons. Western blot analysis showed a distinctive pattern of binding to several neural proteins, including a 210 kd antigen identified as the high molecular weight subunit of neurofilament. No control serum showed a similar pattern of reactivity.
CONCLUSION: Opsoclonus-myoclonus syndrome in childhood is associated with a distinctive pattern of serum IgM and IgG binding to neural tissues and antigens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202608     DOI: 10.1016/s0022-3476(97)70272-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

1.  Opsoclonus myoclonus ataxia syndrome following COVID-19 infection.

Authors:  Ismail Ibrahim Ismail; Walaa A Kamel; Ayman Kilany
Journal:  Acta Neurol Belg       Date:  2022-07-14       Impact factor: 2.471

2.  Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases.

Authors:  Benedikt Maria Huber; Susi Strozzi; Maja Steinlin; Christoph Aebi; Simon Fluri
Journal:  Eur J Pediatr       Date:  2009-09-24       Impact factor: 3.183

Review 3.  Paraneoplastic neurologic syndromes in children: a review article.

Authors:  Samin Alavi
Journal:  Iran J Child Neurol       Date:  2013

4.  Adult-onset opsoclonus-myoclonus-ataxia syndrome as a manifestation of brazilian lyme disease-like syndrome: a case report and review of literature.

Authors:  Angelina Maria Martins Lino; Raphael Ribeiro Spera; Fernando Peixoto Ferraz de Campos; Christian Henrique de Andrade Freitas; Márcio Ricardo Taveira Garcia; Leonardo da Costa Lopes; Aleksander Snioka Prokopowitsch
Journal:  Autops Case Rep       Date:  2014-03-31

5.  Diagnostic value of whole-body MRI in Opsoclonus-myoclonus syndrome: a clinical case series (3 case reports).

Authors:  Corinna Storz; Roland Bares; Martin Ebinger; Rupert Handgretinger; Ilias Tsiflikas; Jürgen F Schäfer
Journal:  BMC Med Imaging       Date:  2019-08-20       Impact factor: 1.930

6.  Myoclonus and COVID-19: A Challenge for the Present, a Lesson for the Future.

Authors:  Anna Latorre; John C Rothwell
Journal:  Mov Disord Clin Pract       Date:  2020-11-02

7.  Spectrum of centrosome autoantibodies in childhood varicella and post-varicella acute cerebellar ataxia.

Authors:  Marvin J Fritzler; Meifeng Zhang; Laura M Stinton; Jerome B Rattner
Journal:  BMC Pediatr       Date:  2003-09-23       Impact factor: 2.125

8.  Opsoclonus-myoclonus syndrome after adenovirus infection.

Authors:  Steffen Syrbe; Andreas Merkenschlager; Matthias K Bernhard; Jens Grosche; Uwe Gerd Liebert; Wolfgang Hirsch; Wolfgang Härtig
Journal:  Springerplus       Date:  2015-10-23

Review 9.  Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review.

Authors:  Jason L Chan; Keely A Murphy; Justyna R Sarna
Journal:  J Neurol       Date:  2021-02-22       Impact factor: 4.849

10.  Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome.

Authors:  Georgina Berridge; David A Menassa; Teresa Moloney; Patrick J Waters; Imogen Welding; Selina Thomsen; Sameer Zuberi; Roman Fischer; A Radu Aricescu; Michael Pike; Russell C Dale; Benedikt Kessler; Angela Vincent; Ming Lim; Sarosh R Irani; Bethan Lang
Journal:  Neurology       Date:  2018-07-25       Impact factor: 9.910

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.